Bloomin' Brands (BLMN) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 adjusted diluted EPS was $0.51 and GAAP diluted EPS was $0.32, with U.S. comparable sales down 0.1% but outperforming the industry, and total revenues at $1.12 billion, down 2.9% year-over-year.
The casual dining industry was softer than anticipated, leading to updated full-year guidance and a focus on guest experience, menu simplification, and digital marketing.
Asset upgrades continue, with 60-65 remodels and 40-45 new openings planned for 2024, including 20 in Brazil.
Off-premises sales remain strong at 24% of U.S. sales, with Carrabba's catering up 180% over two years.
The company is reviewing strategic alternatives for its Brazil operations, including a possible sale.
Financial highlights
Q2 total revenues were $1.12 billion, down 2.9% year-over-year, mainly due to lower comparable sales, net closures/openings, and loss of Brazil VAT exemption.
U.S. comparable sales were down 0.1%; traffic declined 3.8% year-over-year.
Q2 GAAP diluted EPS was $0.32 (vs. $0.70 in 2023); adjusted EPS was $0.51 (vs. $0.70 in 2023).
Adjusted operating margin was 5.7% (vs. 7.8% last year), impacted by higher labor, advertising, and depreciation, partially offset by lower food and beverage costs.
Restaurant-level operating margin was 14.3%, down from 16.4% year-over-year.
Outlook and guidance
Full-year 2024 U.S. comparable sales guidance updated to flat to down 1%, reflecting a softer industry environment.
Adjusted diluted EPS guidance for 2024 is $2.10–$2.30, with a wider range due to industry volatility.
Q3 U.S. comparable sales expected to be flat to down 2%; Q3 adjusted EPS guidance is $0.17–$0.25.
Capital expenditures guidance lowered to $260–$270 million.
Brazil VAT exemption to provide a $0.15 benefit in 2024, mostly in the second half.
Latest events from Bloomin' Brands
- Turnaround strategy, board refresh, and pay-for-performance drive key proxy actions.BLMN
Proxy Filing3 Mar 2026 - Annual meeting to vote on directors, compensation, auditor, and key shareholder proposals.BLMN
Proxy Filing3 Mar 2026 - Q4 2025 saw higher revenues, improved traffic, and a turnaround focus, but lower margins.BLMN
Q4 202525 Feb 2026 - Q3 sales and earnings declined, with Brazil sale and lower guidance amid ongoing share buybacks.BLMN
Q3 202415 Jan 2026 - Q4 earnings and sales fell as traffic lagged, Brazil was refranchised, and turnaround efforts began.BLMN
Q4 202416 Dec 2025 - Board elections, executive pay, and a new incentive plan headline the 2025 proxy.BLMN
Proxy Filing1 Dec 2025 - Proxy filing covers voting matters and capital structure for the upcoming shareholder meeting.BLMN
Proxy Filing1 Dec 2025 - Flat Q2 sales and margin pressure offset by Brazil divestiture and reaffirmed guidance.BLMN
Q2 202523 Nov 2025 - Q1 2025 revenue and margins declined, but net income rose on Brazil sale and cost controls.BLMN
Q1 202521 Nov 2025